My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Dare Bioscience, Inc. - Common Stock (NQ:DARE)

1.860 -0.030 (-1.59%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dare Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 02, 2023

Via Benzinga

Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms ↗

January 09, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Dare Bioscience: Here's What You Need To Know ↗

December 13, 2022

Via Benzinga

Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow ↗

November 14, 2022

Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options.

Via Benzinga

Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?

October 26, 2022

From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...

Via TheNewswire.com

Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?

October 26, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause ↗

October 17, 2022

Via Benzinga

Dare Bioscience: Q1 Earnings Insights ↗

May 12, 2022

Dare Bioscience (NASDAQ:DARE) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗

December 01, 2022

Via Benzinga

Can This Company's Birth Control Patch Disrupt The Contraceptive Market? ↗

October 25, 2022

Via Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Dare Bioscience Q4 Earnings ↗

March 31, 2022

Dare Bioscience (NASDAQ:DARE) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Outlook For Dare Bioscience ↗

August 08, 2022

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Dare...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 25, 2022

Gainers

Via Benzinga

President Biden Mulls Health Emergency For Abortion Access: Report ↗

July 11, 2022

Via Benzinga

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 07, 2022

Gainers

Via Benzinga

EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision ↗

June 27, 2022

Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch.

Via InvestorPlace

3 Women's Health Stocks Are Soaring Following Roe v. Wade Ruling ↗

June 27, 2022

Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in...

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Preview: Dare Bioscience ↗

May 11, 2022

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare...

Via Benzinga

Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment ↗

March 31, 2022

Organon & Co (NYSE: OGN)

Via Benzinga

Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)

March 31, 2022

From Organon & Co.

Via Business Wire

Earnings Preview: Dare Bioscience ↗

March 30, 2022

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare...

Via Benzinga

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 29, 2021

Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 27, 2021

Gainers OptiNose (NASDAQ:OPTN) shares mov...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 09, 2021

Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

35 Stocks Moving In Wednesday's Mid-Day Session ↗

December 08, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.